Home > Practice > Current Affairs > August - 2024 > August 28, 2024
1. Which company launched the oral cholera vaccine, Hillchol, after successful phase 3 trials?
Bharat Biotech has launched the oral cholera vaccine, Hillchol, following successful phase 3 trials that demonstrated its safety. The vaccine was developed under license from Hilleman Laboratories and aims to address the global shortage of cholera vaccine doses. With a production capacity of 200 million doses, Hillchol targets individuals above the age of one, providing a crucial solution to combat cholera globally. Bharat Biotech's launch of Hillchol marks a significant milestone in the fight against cholera.